Purification of soluble immune complexes from serum using polymethylmetacrylate beads coated with conglutinin or C1q. Application to the analysis of the components of in vitro formed immune complexes and of immune complexes occurring in vivo during leishmaniasis
- PMID: 498587
- PMCID: PMC1537812
Purification of soluble immune complexes from serum using polymethylmetacrylate beads coated with conglutinin or C1q. Application to the analysis of the components of in vitro formed immune complexes and of immune complexes occurring in vivo during leishmaniasis
Abstract
A procedure for the isolation of immune complexes from human sera has been developed. Two steps are involved: (1) lipid-free serum is precipitated by polyethylene glycol; (2) the solubilized precipitate is absorbed on a column of polymethylmethacrylate beads coated with conglutinin (K) or C1q; the column is washed, the complexes are then eluted, using 0.02 M EDTA (for K column) or 0.5 M NaCl (for C1q column). This procedure permitted the purification and the characterization of soluble 125I-BSA-anti-BSA, 125 I-tetanus toxoid-anti-tetanus toxoid, and 125-I-HBsAg-anti-HBsAg complexes made in vitro in the presence of fresh human serum. The isolated complexes were shown to contain antigen, antibody, C1q, C1r, C1s and C3. When normal human serum was submitted to such a procedure, no detectable amount of protein was present in the final eluted fraction. Immune complexes formed in vivo were also purified by conglutinin column from the serum of a patient with disseminated leishmaniasis. The isolated material was found to contain IgM, IgG, C1q, C1r, C1s, C3c and C3d. The purified complexes dissociated at acid pH were found to contain anti-IgG and anti-leishmania antibodies.
Similar articles
-
Anti-C1q column: ligand specific purification of immune complexes from human serum or plasma. Analysis of the interaction between C1q and immune complexes.Clin Exp Immunol. 1982 Jun;48(3):705-14. Clin Exp Immunol. 1982. PMID: 6811171 Free PMC article.
-
Immune complexes in Hodgkin's disease: isolation, immunochemical and physico-chemical analysis.Clin Exp Immunol. 1983 Aug;53(2):308-18. Clin Exp Immunol. 1983. PMID: 6411401 Free PMC article.
-
125I-C1q binding activity of soluble antigen-antibody complexes formed in vitro.J Clin Lab Immunol. 1982 Nov;9(2):121-31. J Clin Lab Immunol. 1982. PMID: 6984078
-
Possible mechanisms of degradation of C1q in vivo and in vitro: role of macrophages.Behring Inst Mitt. 1989 Jul;(84):42-6. Behring Inst Mitt. 1989. PMID: 2529843 Review.
-
Control of immune complexes by the classical pathway.Behring Inst Mitt. 1989 Jul;(84):111-20. Behring Inst Mitt. 1989. PMID: 2529842 Review.
Cited by
-
Inhibition of immune precipitation by complement.Clin Exp Immunol. 1980 Nov;42(2):387-94. Clin Exp Immunol. 1980. PMID: 6781802 Free PMC article.
-
Immune complexes in retinitis pigmentosa.Br J Ophthalmol. 1984 Nov;68(11):811-4. doi: 10.1136/bjo.68.11.811. Br J Ophthalmol. 1984. PMID: 6333894 Free PMC article.
-
Partial H (beta 1H) deficiency and glomerulonephritis in two families.J Clin Immunol. 1982 Apr;2(2):110-7. doi: 10.1007/BF00916894. J Clin Immunol. 1982. PMID: 6461667
-
Anti-C1q column: ligand specific purification of immune complexes from human serum or plasma. Analysis of the interaction between C1q and immune complexes.Clin Exp Immunol. 1982 Jun;48(3):705-14. Clin Exp Immunol. 1982. PMID: 6811171 Free PMC article.
-
The isolation of the antibody moieties of immune complexes from serum by the pepsin digestion of conglutinin-anti-conglutinin complexes.Clin Exp Immunol. 1981 Nov;46(2):250-8. Clin Exp Immunol. 1981. PMID: 6279342 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous